Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation

Lung Cancer ◽

10.1016/j.lungcan.2015.06.002 ◽

2015 ◽

Vol 90 (1) ◽

pp. 65-70 ◽

Author(s):

Naruo Yoshimura ◽

Shinzoh Kudoh ◽

Shigeki Mitsuoka ◽

Naoki Yoshimoto ◽

Takako Oka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Study ◽

Combination Regimen ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402)

Lung Cancer ◽

10.1016/j.lungcan.2019.03.030 ◽

2019 ◽

Vol 135 ◽

pp. 175-180 ◽

Author(s):

Toshihide Yokoyama ◽

Hiroshige Yoshioka ◽

Daichi Fujimoto ◽

Yoshiki Demura ◽

Katsuya Hirano ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

Starting Dose ◽

First Line Treatment

Download Full-text

A phase II study of low-dose afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402)

Annals of Oncology ◽

10.1093/annonc/mdx671.054 ◽

2017 ◽

Vol 28 ◽

pp. x142-x143 ◽

Author(s):

D. Fujimoto ◽

T. Yokoyama ◽

H. Yoshioka ◽

Y. Demura ◽

K. Hirano ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Low Dose ◽

Egfr Mutation ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer

Thoracic Cancer ◽

10.1111/1759-7714.13462 ◽

2020 ◽

Author(s):

Po‐Lan Su ◽

Chian‐Wei Chen ◽

Yi‐Lin Wu ◽

Chien‐Chung Lin ◽

Wu‐Chou Su

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer

The Oncologist ◽

10.1634/theoncologist.2018-0858 ◽

2018 ◽

Vol 24 (4) ◽

pp. 459 ◽

Author(s):

Akihiro Yoshimura ◽

Yusuke Chihara ◽

Koji Date ◽

Nobuyo Tamiya ◽

Yoshizumi Takemura ◽

...

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

815 Elderly patients (pts) with unresectable localised or metastatic non-small-cell-lung-cancer (NSCLC): results of a phase II study with oral navelbineâ (nvb) given as a weekly monotherapy and first line treatment

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90840-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S244-S245

Author(s):

U. Gatzemeier ◽

F. De Marinis ◽

C. Manegold ◽

P. Mali ◽

L. Portalone ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(97)85866-2 ◽

1997 ◽

Vol 33 ◽

pp. S236 ◽

Author(s):

N. Androulakis ◽

C. Kourousis ◽

S. Kakolyris ◽

A.M. Dimopoulos ◽

E. Papadakis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

O-279 A multicenter randomised phase II study of cisplatin, etoposide, gemcitabine (PEG) versus cisplatin, gemcitabine (PG) as first line treatment in patients with small cell lung cancer (SCLC): Preliminary results

Lung Cancer ◽

10.1016/s0169-5002(03)91937-4 ◽

2003 ◽

Vol 41 ◽

pp. S81-S82

Author(s):

Filippo De Marinis ◽

Cesare Gridelli ◽

Marco Lombardo ◽

Luca Paoluzzi ◽

Francisco Ferraù ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Multicenter phase II study of the combination of carboplatin and paclitaxel as first line treatment in elderly patients with advanced non small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7239 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7239-7239 ◽

Author(s):

I. Okamoto ◽

E. Moriyama ◽

H. Kishi ◽

M. Nomura ◽

F. Imamura ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

A phase II study of erlotinib as first-line treatment of advanced non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7073 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7073-7073 ◽

Author(s):

G. Giaccone ◽

T. Lechevalier ◽

N. Thatcher ◽

E. Smit ◽

M. Janmaat ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text